Polaris Group Overview
- Year Founded
-
1988

- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Polaris Group General Information
Description
Provider of healthcare and nursing consultancy services intended for Long Term Care (LTC) Communities. The company specializes in offering Medicare compliance, clinical consulting, benchmarking analytics via its Key Indicator Trend (KIT) reports, outsourced billing solutions, and specialized staffing placements, helping post-acute health care providers in realizing accurate reimbursement amid increasing regulatory complexities.
Contact Information
Website
www.polaris-group.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Practice Management (Healthcare)
Other Industries
Education and Training Services (B2B)
Parent Company
Primary Office
- 3030 North Rocky Point Drive
- Suite 240
- Tampa, FL 33607
- United States
+1 (813) 000-0000
Polaris Group Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Polaris Group Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of healthcare and nursing consultancy services intended for Long Term Care (LTC) Communities. The company speci
Practice Management (Healthcare)
Tampa, FL
000000000000
Polaris Group Competitors (4)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Radrx | Corporation | Palm City, FL | ||||
000000 00000000 | Private Equity-Backed | Naperville, IL | 000 | 000000000 | ||
00000000 000000000 | Corporation | Jacksonville, FL | ||||
00000000 | Private Equity-Backed | South Jordan, UT | 0000 | 00.000 | 000000000 | 00.000 |
Polaris Group Patents
Polaris Group Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3039796-A1 | Formulations of pegylated arginine deiminase | Pending | 02-Nov-2016 | 000000000 | |
EP-3534963-A2 | Formulations of pegylated arginine deiminase | Pending | 02-Nov-2016 | 000000000 | |
EP-3534963-A4 | Formulations of pegylated arginine deiminase | Pending | 02-Nov-2016 | 000000000 | 0 |
US-20180296652-A1 | Formulations of pegylated arginine deiminase | Pending | 02-Nov-2016 | 000000000 | 0 |
AU-2015317848-A1 | Arginine deiminase with reduced cross-reactivity toward adi - peg 20 antibodies for cancer treatment | Active | 16-Sep-2014 | A61K38/50 |
Polaris Group Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Chuck Cave | Co-Owner, President & Chief Operating Officer | ||
Jack Fitzgibbons | Chief Operating Officer |
Polaris Group Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|